2012 annual financial data
Summit Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -265.64%.
Operating income was -4,577,000 GBP and net income was -4,225,000 GBP.
Operating cash flow was -5,033,880 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,895,000 GBP
- Operating income
- -4,577,000 GBP
- Net income
- -4,225,000 GBP
- Operating cash flow
- -5,033,880 GBP